The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujihara, S. M.
Right arrow Articles by Nadler, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujihara, S. M.
Right arrow Articles by Nadler, S. G.
The Journal of Immunology, 2000, 165: 1004-1012.
Copyright © 2000 by The American Association of Immunologists

A D-Amino Acid Peptide Inhibitor of NF-{kappa}B Nuclear Localization Is Efficacious in Models of Inflammatory Disease

Sheri M. Fujihara, Jeffrey S. Cleaveland, Laura S. Grosmaire, Karen K. Berry, Karen A. Kennedy, James J. Blake, James Loy, Bruce M. Rankin, Jeffrey A. Ledbetter and Steven G. Nadler1

Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543

The transcription factor NF-{kappa}B regulates many genes involved in proinflammatory and immune responses. The transport of NF-{kappa}B into the nucleus is essential for its biologic activity. We describe a novel, potent, and selective NF-{kappa}B inhibitor composed of a cell-permeable peptide carrying two nuclear localization sequences (NLS). This peptide blocks NF-{kappa}B nuclear localization, resulting in inhibition of cell surface protein expression, cytokine production, and T cell proliferation. The peptide is efficacious in vivo in a mouse septic shock model as well as a mouse model of inflammatory bowel disease, demonstrating that NF-{kappa}B nuclear import plays a role in these acute inflammatory disease models.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
J. W. Zmijewski, X. Zhao, Z. Xu, and E. Abraham
Exposure to hydrogen peroxide diminishes NF-{kappa}B activation, I{kappa}B-{alpha} degradation, and proteasome activity in neutrophils
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C255 - C266.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Li, A. L. Carr, E. J. Donald, J. J. Skitzki, R. Okuyama, L. M. Stoolman, and A. E. Chang
Synergistic Effects of IL-12 and IL-18 in Skewing Tumor-Reactive T-Cell Responses Towards a Type 1 Pattern
Cancer Res., February 1, 2005; 65(3): 1063 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takada, S. Singh, and B. B. Aggarwal
Identification of a p65 Peptide That Selectively Inhibits NF-{kappa} B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-{kappa}B-mediated Gene Expression and Up-regulation of Apoptosis
J. Biol. Chem., April 9, 2004; 279(15): 15096 - 15104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Strassheim, K. Asehnoune, J.-S. Park, J.-Y. Kim, Q. He, D. Richter, S. Mitra, J. Arcaroli, K. Kuhn, and E. Abraham
Modulation of bone marrow-derived neutrophil signaling by H2O2: disparate effects on kinases, NF-{kappa}B, and cytokine expression
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C683 - C692.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. C. Harnish, L. M. Albert, Y. Leathurby, A. M. Eckert, A. Ciarletta, M. Kasaian, and J. C. Keith Jr.
Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease
Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G118 - G125.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. Macdonald, H. F. Galley, and N. R. Webster
Oxidative stress and gene expression in sepsis
Br. J. Anaesth., February 1, 2003; 90(2): 221 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. S. Kabouridis, M. Hasan, J. Newson, D. W. Gilroy, and T. Lawrence
Inhibition of NF-{kappa}B Activity by a Membrane-Transducing Mutant of I{kappa}B{alpha}
J. Immunol., September 1, 2002; 169(5): 2587 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
F. D'Acquisto, M. J. May, and S. Ghosh
Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies
Mol. Interv., February 1, 2002; 2(1): 22 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. G. Kupfner, J. J. Arcaroli, H.-K. Yum, S. G. Nadler, K.-Y. Yang, and E. Abraham
Role of NF-{kappa}B in Endotoxemia-Induced Alterations of Lung Neutrophil Apoptosis
J. Immunol., December 15, 2001; 167(12): 7044 - 7051.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.